NCT00745316View on ClinicalTrials.gov

Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency

PHASE2TerminatedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Renal InsufficiencyHeart Failure
Interventions
DRUG

Tonapofylline

Oral Tonapofylline - 2 capsules bid

DRUG

Placebo

Oral placebo - 2 capsules bid

Trial Locations (30)

10461

The Bronx

17602

Lancaster

21201

Baltimore

24014

Roanoke

32174

Ormond Beach

32209

Jacksonville

32901

Melbourne

35801

Huntsville

36608

Mobile

38138

Germantown

42303

Owensboro

45219

Cincinnati

45267

Cincinnati

46260

Indianapolis

52242

Iowa City

53511

Beloit

53792

Madison

55415

Minneapolis

60153

Maywood

60612

Chicago

68506

Lincoln

73120

Oklahoma City

80218

Denver

85251

Scottsdale

85710

Tucson

90210

Beverly Hills

92103

San Diego

06606

Bridgeport

02114

Boston

02115

Boston

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY